Weeks later, Lilly responded, once again cutting the price of its GLP-1 weight loss option, Zepbound, when purchased through the direct-to-consumer (DTC) platform LillyDirect
When you combine topiramate and Zepbound, you must be aware of how their side effect profiles might overlap or intensify
People are watching life-changing outcomes, but there is one big question
Tirzepatide works by activating GIP and GLP-1 receptors, which enhance insulin secretion in a glucose-dependent manner, suppress glucagon release, slow gastric emptying, and reduce appetite through central nervous system pathways

Key Takeaways BCBS coverage for Zepbound varies by state and plan type: There is no single BCBS policy each state affiliate and employer group sets its own formulary Prior authorization is almost always required: Even plans that cover Zepbound require clinical documentation before approving claims BMI thresholds typically apply: Most BCBS plans require a BMI 30, or 27 with a weight-related comorbidity like type 2 diabetes or hypertension Some BCBS affiliates have dropped GLP-1 coverage entirely: BCBS Michigan removed all GLP-1 weight loss drugs from fully insured commercial plans starting January 2025 Research-grade tirzepatide exists for laboratory use: Not a substitute for prescription medication, but available at significantly lower cost for research applications Zepbound (tirzepatide) launched in late 2023 as Eli Lilly's dedicated weight management version of Mounjaro

Adverse effects associated with tirzepatide use in patients at increased cardiovascular risk: a systematic review with meta-analysis